These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20443369)

  • 21. Obesity and NAFLD: the role of bacteria and microbiota.
    Duseja A; Chawla YK
    Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
    McPhee JB; Schertzer JD
    Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulinoresistancy in Man: from mechanisms to nutritional interference].
    Sultan A
    Biol Aujourdhui; 2017; 211(2):189-196. PubMed ID: 29236670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Going with his gut bacteria.
    Wenner M
    Sci Am; 2008 Jul; 299(1):90, 92. PubMed ID: 18623970
    [No Abstract]   [Full Text] [Related]  

  • 25. [The intestinal microbiota helps shapping the adaptive immune response against viruses].
    Chassaing B
    Med Sci (Paris); 2015 Apr; 31(4):355-7. PubMed ID: 25958747
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
    Chambers ES; Preston T; Frost G; Morrison DJ
    Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal microbiota and obesity.
    Blaut M; Klaus S
    Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dysmetabolic syndrome: epidemiology and etiology.
    Sauerwein HP
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():1-13. PubMed ID: 16820727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
    Komori T; Morikawa Y
    Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Changes of intestinal microecology during early infancy and subsequent risk of obesity].
    Li F; Zhang L
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):506-9. PubMed ID: 25224055
    [No Abstract]   [Full Text] [Related]  

  • 31. Obesity, diabetes, and the gut microbiome: an updated review.
    Singer-Englar T; Barlow G; Mathur R
    Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):3-15. PubMed ID: 30791839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota.
    Sun SS; Wang K; Ma K; Bao L; Liu HW
    Chin J Nat Med; 2019 Jan; 17(1):3-14. PubMed ID: 30704621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota: a natural adjuvant for vaccination.
    Pabst O; Hornef M
    Immunity; 2014 Sep; 41(3):349-351. PubMed ID: 25238091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mannan-oligosaccharide modulates the obesity and gut microbiota in high-fat diet-fed mice.
    Wang H; Zhang X; Wang S; Li H; Lu Z; Shi J; Xu Z
    Food Funct; 2018 Jul; 9(7):3916-3929. PubMed ID: 29974116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance as the underlying cause for the metabolic syndrome.
    Lann D; LeRoith D
    Med Clin North Am; 2007 Nov; 91(6):1063-77, viii. PubMed ID: 17964909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and Toll-like receptor 5.
    Rumbo M; Nempont C; Kraehenbuhl JP; Sirard JC
    FEBS Lett; 2006 May; 580(12):2976-84. PubMed ID: 16650409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut reactions.
    Wallis C
    Sci Am; 2014 Jun; 310(6):30, 33. PubMed ID: 25004571
    [No Abstract]   [Full Text] [Related]  

  • 39. Combinatory biotechnological intervention for gut microbiota.
    Khangwal I; Shukla P
    Appl Microbiol Biotechnol; 2019 May; 103(9):3615-3625. PubMed ID: 30847544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity.
    Elhady M; Elazab AAAM; Bahagat KA; Abdallah NA; Ibrahim GE
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):19-26. PubMed ID: 30530906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.